This Article details the methods used for rigorous assessment of disease interventions in a multicenter preclinical trial. Using stroke models as proof of concept, it offers adaptable protocols for any field requiring robust preclinical validation.
- Jessica Lamb
- Karisma Nagarkatti
- Patrick Lyden